{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:01:32Z","timestamp":1787508092694,"version":"build-2736575974"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Domp\u00e9 farmaceutici S.p.A."},{"name":"Domp\u00e9 SpA"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.pupt.2019.03.003","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T02:53:38Z","timestamp":1552272818000},"page":"79-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Antitussive therapy: A role for levodropropizine"],"prefix":"10.1016","volume":"56","author":[{"given":"Surinder","family":"Birring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"de Blasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter V.","family":"Dicpinigaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Lanata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Saibene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Zanasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2019.03.003_bib1","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1183\/09031936.00101006","article-title":"ERS guidelines on the assessment of cough","volume":"29","author":"Morice","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2019.03.003_bib2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1124\/pr.111.005116","article-title":"Antitussive drugs\u2014past, present, and future","volume":"66","author":"Dicpinigaitis","year":"2014","journal-title":"Pharmacol. Rev."},{"issue":"9974","key":"10.1016\/j.pupt.2019.03.003_bib3","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(14)61255-1","article-title":"P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study","volume":"385","author":"Abdulqawi","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.pupt.2019.03.003_bib4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/thx.2006.060087","article-title":"Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms","volume":"61","author":"Ford","year":"2006","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.pupt.2019.03.003_bib5","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1378\/chest.127.5.1710","article-title":"Chronic idiopathic cough: a discrete clinical entity?","volume":"127","author":"Haque","year":"2005","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.pupt.2019.03.003_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/pupt.1997.0083","article-title":"Efficacy and tolerability of levodropropizine in adult patients with non-productive cough. Comparison with dextromethorphan","volume":"10","author":"Catena","year":"1997","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"1","key":"10.1016\/j.pupt.2019.03.003_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1183\/09031936.98.12010097","article-title":"Efficacy and safety of levodropropizine and dihydrocodeine on non-productive cough in primary and metastatic lung cancer","volume":"12","author":"Luporini","year":"1998","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2019.03.003_bib8","first-page":"9","volume":"vol. 29","author":"Bossi","year":"1994"},{"issue":"2","key":"10.1016\/j.pupt.2019.03.003_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0952-0600(92)90033-D","article-title":"Peripheral site of action of levodropropizine in experimentally-induced cough: role of sensory neuropeptides","volume":"5","author":"Lavezzo","year":"1992","journal-title":"Pulm. Pharmacol."},{"issue":"5","key":"10.1016\/j.pupt.2019.03.003_bib10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1476-5381.1996.tb15271.x","article-title":"Effects of levodropropizine on vagal afferent C-fibres in the cat","volume":"117","author":"Shams","year":"1996","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.pupt.2019.03.003_bib11","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.chest.2017.02.001","article-title":"A randomized clinical trial comparing the effects of antitussive agents on respiratory center output in patients with chronic cough","volume":"151","author":"Mannini","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2019.03.003_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1745-9974-6-9","article-title":"Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on cough","volume":"6","author":"Molassiotis","year":"2010","journal-title":"Cough"},{"issue":"4","key":"10.1016\/j.pupt.2019.03.003_bib13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.pupt.2006.12.003","article-title":"Encoding of the cough reflex","volume":"20","author":"Canning","year":"2006","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.pupt.2019.03.003_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pupt.2017.05.010","article-title":"Blocking voltage-gated sodium channels as a strategy to suppress pathological cough","volume":"47","author":"Sun","year":"2017","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"3","key":"10.1016\/j.pupt.2019.03.003_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/pupt.2002.0338","article-title":"Hypersensitivity of bronchopulmonary C-fibers induced by airway mucosal inflammation: cellular mechanisms","volume":"15","author":"Lee","year":"2002","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"1","key":"10.1016\/j.pupt.2019.03.003_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1745-9974-9-8","article-title":"Molecular signaling and targets from itch: lessons for cough","volume":"6","author":"LaVinka","year":"2013","journal-title":"Cough"},{"key":"10.1016\/j.pupt.2019.03.003_bib17","doi-asserted-by":"crossref","first-page":"R369","DOI":"10.1152\/ajpregu.00044.2010","article-title":"Encoding of the cough reflex in anesthetized Guinea pigs","volume":"300","author":"Canning","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.pupt.2019.03.003_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000126057","article-title":"Immunohistochemical localization of transient receptor potential vanilloid subtye 1 in the trachea of ovalbumin sensitized Guinea \u2013 pigs","volume":"146","author":"Watanabe","year":"2008","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"Pt 2","key":"10.1016\/j.pupt.2019.03.003_bib19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1113\/jphysiol.2003.057885","article-title":"Identification of the tracheal and laryngeal afferent neurones mediating cough in anaesthetized Guinea-pigs","volume":"557","author":"Canning","year":"2004","journal-title":"J. Physiol."},{"issue":"4","key":"10.1016\/j.pupt.2019.03.003_bib20","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.chest.2017.05.016","article-title":"Translating cough mechanisms into better cough suppressants","volume":"152","author":"Keller","year":"2017","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.pupt.2019.03.003_bib21","doi-asserted-by":"crossref","first-page":"1701571","DOI":"10.1183\/13993003.01571-2017","article-title":"New drug targets for chronic cough: research you can literally sink your teeth into!","volume":"50","author":"Jolley","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2019.03.003_bib22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/thoraxjnl-2011-201443","article-title":"Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin","volume":"67","author":"Grace","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2019.03.003_bib23","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1164\/rccm.200402-174OC","article-title":"Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough","volume":"170","author":"Groneberg","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.pupt.2019.03.003_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/pulp.1993.1023","article-title":"A comparative study of the effects of citric acid, capsaicin and resiniferatoxin on the cough challenge in Guinea-pig and man","volume":"6","author":"Laude","year":"1993","journal-title":"Pulm. Pharmacol."},{"key":"10.1016\/j.pupt.2019.03.003_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2017.12.008","article-title":"Pulm Pharmacol Ther. The research of the possible mechanism and the treatment for capsaicin-induced cough","volume":"49","author":"Zhang","year":"2018","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"10","key":"10.1016\/j.pupt.2019.03.003_bib26","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1164\/rccm.201704-0769OC","article-title":"XEN-D0501, a novel transient receptor potential vanilloid 1 antagonist, does not reduce cough in patients with refractory cough","volume":"196","author":"Belvisi","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.pupt.2019.03.003_bib27","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.3390\/ph9030045","article-title":"TRPV1 and TRPM8 in treatment of chronic cough","volume":"9","author":"Millqvist","year":"2016","journal-title":"Pharmaceuticals"},{"issue":"29_suppl","key":"10.1016\/j.pupt.2019.03.003_bib28","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2015.33.29_suppl.2","article-title":"A placebo-controlled trial of aprepitant for cough in lung cancer","volume":"33","author":"Harle","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"VOLCANO-1","key":"10.1016\/j.pupt.2019.03.003_bib29","first-page":"A2672","article-title":"The neurokinin-1 receptor antagonist orvepitant is a novel anti-tussive therapy for chronic refractory cough: results from a phase 2 study","volume":"195","author":"Smith","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2019.03.003_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/5584_2016_244","article-title":"Airway Defense Control Mediated via Voltage-Gated Sodium Channels","volume":"921","author":"Kocmalova","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.pupt.2019.03.003_bib31","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00782-2017","article-title":"Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy","volume":"50","author":"Wortley","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.pupt.2019.03.003_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1124\/jpet.114.221283","article-title":"The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough","volume":"353","author":"Makwana","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pupt.2019.03.003_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pupt.2016.08.001","article-title":"Antitussive effect of carcaicin chloride in patients with chronic coughs and idiopathic intestinal pneumorias: a pilot study","volume":"40","author":"Lavorini","year":"2016","journal-title":"Pulm.pharm.Ther."},{"key":"10.1016\/j.pupt.2019.03.003_bib34","series-title":"Lung the Impact of Chronic Cough: a Cross-Sectional European Survey","first-page":"401","volume":"vol. 193","author":"Chamberlain","year":"2015"},{"key":"10.1016\/j.pupt.2019.03.003_bib36","series-title":"FDA Drug Safety Communication","year":"2017"},{"issue":"4","key":"10.1016\/j.pupt.2019.03.003_bib37","first-page":"59","article-title":"Badari birur. Psychopharmacology bulletin. Dextromethorphan in cough syrup: the poor","volume":"47","author":"Bridgette","year":"2017","journal-title":"Man\u2019s Psychosis"},{"issue":"8","key":"10.1016\/j.pupt.2019.03.003_bib38","first-page":"1156","article-title":"Gas chromatographic-mass spectrometric determination of levodropropizine plasma levels in healthy volunteers","volume":"38","author":"Zaratin","year":"1988","journal-title":"Arzneimittelforschung"},{"issue":"8","key":"10.1016\/j.pupt.2019.03.003_bib39","first-page":"1141","article-title":"Antitussive properties of levodropropizine","volume":"38","author":"Malandrino","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.pupt.2019.03.003_bib40","article-title":"Dis. Effect of levodropropizine on airway hyperreacticity induced by acute cigarette smoke exposure in Guinea-pigs","volume":"143","author":"Daffonchio","year":"1991","journal-title":"Am. Rev. Resp"},{"issue":"5\u20136","key":"10.1016\/j.pupt.2019.03.003_bib41","first-page":"257","article-title":"Effectiveness of levodropropizine against cigarette smoke-induced airway hyperreactivity: possible mechanism","volume":"228","author":"Daffonchio","year":"1993","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pupt.2019.03.003_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(93)90159-F","article-title":"Levodropropizine reduces capsaicin- and substance P-induced plasma extravasation in the rat trachea","volume":"243","author":"Yamawaki","year":"1993","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pupt.2019.03.003_bib43","first-page":"153","article-title":"Antitussive effects of levodropropizine in the dog","volume":"44","author":"Munt","year":"1994","journal-title":"Arzneimittelforschung"},{"issue":"12","key":"10.1016\/j.pupt.2019.03.003_bib44","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00011-013-0664-6","article-title":"Effects of four antitussives on airway neurogenic inflammation in a Guinea pig model of chronic cough induced by cigarette smoke exposure","volume":"vol. 62","author":"Luo","year":"2013","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.pupt.2019.03.003_bib45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/jpet.115.230227","article-title":"Ozone-induced hypertussive responses in rabbits and Guinea pigs","volume":"357","author":"Clay","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.pupt.2019.03.003_bib46","first-page":"1159","article-title":"Antitussive activity and respiratory system effects of levodropropizine in man","volume":"38","author":"Bossi","year":"1988","journal-title":"Arzneimittelforschung"},{"issue":"8","key":"10.1016\/j.pupt.2019.03.003_bib47","first-page":"1163","article-title":"Clinical trials with the new antitussive levodropropizine in adult bronchitic patients","volume":"38","author":"Allegra","year":"1988","journal-title":"Arzneimittelforschung"},{"issue":"14","key":"10.1016\/j.pupt.2019.03.003_bib48","first-page":"594","article-title":"Levodropropizine effectiveness on nocturnal cough in asthmatic children","volume":"4","author":"Fiocchi","year":"1991","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2019.03.003_bib49","volume":"vol. 13","author":"Di Stefano","year":"1992"},{"key":"10.1016\/j.pupt.2019.03.003_bib50","first-page":"9","article-title":"Levodropropizine in children with bronchitis","volume":"22","author":"Kim","year":"2002","journal-title":"Diagn Treat"},{"key":"10.1016\/j.pupt.2019.03.003_bib51","series-title":"Multidiscip Respir Med. Levodropropizine for Treating Cough in Adult and Children: a Meta-Analysis of Published Studies","first-page":"19","volume":"vol. 10","author":"Zanasi","year":"2015"},{"key":"10.1016\/j.pupt.2019.03.003_bib52","series-title":"Giornale Italiano di Ricerche Cliniche e Terapeutiche. L\u2019impiego dell\u2019antitosse levodropropizina in pazienti affetti da neoplasia broncopolmonare","first-page":"105","volume":"vol. 11","author":"Marchioni","year":"1990"},{"key":"10.1016\/j.pupt.2019.03.003_bib53","first-page":"104","article-title":"Controllo della tosse nella tubercolosi con levodropropizine. Anno X","volume":"76","author":"Di Pisa","year":"1988","journal-title":"Hosp. Manag."},{"issue":"1","key":"10.1016\/j.pupt.2019.03.003_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-9974-8-1","article-title":"An observational study on cough in children: epidemiology, impact on quality of sleep and treatment outcome","volume":"8","author":"De Blasio","year":"2012","journal-title":"Cough"},{"key":"10.1016\/j.pupt.2019.03.003_bib55","first-page":"PA3852","volume":"vol. 46","author":"Zanasi","year":"2015"},{"issue":"8","key":"10.1016\/j.pupt.2019.03.003_bib56","first-page":"1150","article-title":"Safety and toxicological profile of the new antitussive levodropropizine","volume":"38","author":"Bestetti","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.pupt.2019.03.003_bib57","first-page":"233","volume":"vol. 53","author":"F\u00e4rber","year":"2015"},{"key":"10.1016\/j.pupt.2019.03.003_bib58","series-title":"Terapie Essenziali in Clinica. Multicentric Study on Tolerability and Efficacy of Levodropropizine, a New Antitussive Drug, in a Wide Pediatric Study Group","first-page":"3","volume":"vols. 4\u201389","author":"Tamburrano","year":"1989"},{"key":"10.1016\/j.pupt.2019.03.003_bib59","first-page":"8","article-title":"Multincentric study on efficacy and tolerability of levodropropizine: a new antitussive drug","volume":"3","author":"Cogo","year":"1989","journal-title":"Farmacia"},{"issue":"suppl","key":"10.1016\/j.pupt.2019.03.003_bib60","first-page":"21","article-title":"Levodropropizine effect (LD) on mechanically stimulated cough in restrictive pulmonary patients with and without pleurisy","volume":"4","author":"Martin","year":"1991","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.pupt.2019.03.003_bib61","first-page":"261","article-title":"Efficacy and safety of the use of levodropropizine in patients with chronic interstitial lung diseases","volume":"136","author":"Gunella","year":"1991","journal-title":"Clin. Ter."},{"key":"10.1016\/j.pupt.2019.03.003_bib62","series-title":"A Preliminary Report on 1304 Patients. Post Marketing Surveillance","first-page":"191","article-title":"Post-marketing surveillance on levodropropizine: a new antitussive agent","volume":"vol. 5","author":"Romandini","year":"1991"},{"issue":"3","key":"10.1016\/j.pupt.2019.03.003_bib63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/030006059502300304","article-title":"Efficacy and tolerability of levodropropizine and dropropizine in children with non-productive cough","volume":"23","author":"Banderali","year":"1995","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.pupt.2019.03.003_bib64","first-page":"29","volume":"vol. 11","author":"Zanasi","year":"2016"},{"issue":"6","key":"10.1016\/j.pupt.2019.03.003_bib65","first-page":"393","article-title":"Evaluation of the safety of antitussive agents during respiratory rehabilitation. A clinical study of L-dropropizine","volume":"133","author":"M1","year":"1990","journal-title":"Clin. Ter."},{"issue":"1","key":"10.1016\/j.pupt.2019.03.003_bib66","first-page":"33","article-title":"Enantioselective effects of levodropropizine and dropropizine on psychomotor functions in normal volunteers: a placebo-controlled, double-blind comparative study","volume":"19","author":"Gatti","year":"1993","journal-title":"Drugs Exp. Clin. Res."},{"issue":"5","key":"10.1016\/j.pupt.2019.03.003_bib67","first-page":"519","article-title":"Evaluation of the treatment with levodropropizine of respiratory diseases in children","volume":"11","author":"Fiocchi","year":"1989","journal-title":"Pediatr. Med. e Chir."},{"issue":"4","key":"10.1016\/j.pupt.2019.03.003_bib68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1094-5539(03)00053-1","article-title":"Levodropropizine does not affect P0.1 and breathing pattern in healthy volunteers and patients with chronic respiratory impairment","volume":"16","author":"Bruschi","year":"2003","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.pupt.2019.03.003_bib69","first-page":"227","article-title":"Attivit\u00e0 della levodropropizina in pazienti ipercapnici ed ipossiemici: studio controllato verso placebo","volume":"29","author":"Gunella","year":"1990","journal-title":"Pneumologica"},{"key":"10.1016\/j.pupt.2019.03.003_bib70","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1745-9974-7-7","article-title":"Cough management: a practical approach","volume":"7","author":"De Blasio","year":"2011","journal-title":"Cough"},{"key":"10.1016\/j.pupt.2019.03.003_bib71","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1378\/chest.129.1_suppl.25S","article-title":"Introduction to the diagnosis and management of cough. ACCP evidence-based clinical practice guidelines","volume":"129","author":"Irwin","year":"2006","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.pupt.2019.03.003_bib72","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.pupt.2006.11.001","article-title":"The problem of cough and development of novel antitussives","volume":"20","author":"Barnes","year":"2007","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"2 Suppl Managing","key":"10.1016\/j.pupt.2019.03.003_bib73","doi-asserted-by":"crossref","first-page":"133S","DOI":"10.1378\/chest.114.2_Supplement.133S","article-title":"Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians","volume":"114","author":"Irwin","year":"1998","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.pupt.2019.03.003_bib74","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/thorax.58.4.339","article-title":"Development of a symptom specific health status measure for patients with chronic cough: leicester Cough Questionnaire (LCQ)","volume":"58","author":"Birring","year":"2003","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.pupt.2019.03.003_bib75","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1378\/chest.121.4.1123","article-title":"Evaluation of a cough-specific quality-of-life questionnaire","volume":"121","author":"French","year":"2002","journal-title":"Chest"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553918302852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553918302852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:29:19Z","timestamp":1761082159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553918302852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":74,"alternative-id":["S1094553918302852"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2019.03.003","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitussive therapy: A role for levodropropizine","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2019.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}